Register Cart 0

Generic placeholder image

Current Drug Delivery

Editor-in-Chief

ISSN (Print): 1567-2018
ISSN (Online): 1875-5704

Back Subscribe

Opinion Article

Use of Clays as Nanocarriers of First-Line Tuberculostatic Drugs

Author(s): Esperanza Carazo*, Ana Borrego-Sanchez, Carola Aguzzi, Pilar Cerezo and Cesar Viseras

Volume 14, Issue 7, 2017

Page: [902 - 903] Pages: 2

DOI: 10.2174/1567201813666160714160727

Price: $65

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

23

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Mesenchymal Stem Cells: A New Generation of Therapeutic Agents as Vehicles in Gene Therapy
Current Gene Therapy

Costing Human Rights and Community Support Interventions as a Part of Universal Access to HIV Treatment and Care in a Southern African Setting
Current HIV Research

Editorial
Current Drug Therapy

Drug Resistance Mutations from Whole Blood Proviral DNA Among Patients on Antiretroviral Drugs in Zimbabwe
Current HIV Research

Nucleotide Second Messenger Signaling as a Target for the Control of Bacterial Biofilm Formation
Current Topics in Medicinal Chemistry

Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets

Recent Applications of Click Reaction in the Syntheses of 1,2,3-triazoles
Current Organic Synthesis

Effective Therapy with the Neuroleptic Thioridazine as an Adjunct to Second Line of Defence Drugs, and the Potential that Thioridazine Offers for New Patents that Cover a Variety of “New Uses”
Recent Patents on Anti-Infective Drug Discovery

Diagnostic Accuracy of Monocyte Chemotactic Protein (MCP)-2 as Biomarker in Response to PE35/PPE68 Proteins: A Promising Diagnostic Method for the Discrimination of Active and Latent Tuberculosis
Protein & Peptide Letters

Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors
Current HIV Research

Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach
Current Drug Targets

Toward Integrase Defective Lentiviral Vectors for Genetic Immunization
Current HIV Research

A Systematic and Meta-Analysis Study on the Prevalence of Tuberculosis and Relative Risk Factors for Prisoners in Iran
Infectious Disorders - Drug Targets

HIV Vaccines: A Global Perspective
Current Molecular Medicine

Recent Developments in Synthetic Oligosaccharide-Based Bacterial Vaccines
Current Topics in Medicinal Chemistry

C-Type Lectins on Dendritic Cells and Their Interaction with Pathogen-Derived and Endogenous Glycoconjugates
Current Protein & Peptide Science

Lead Molecules for Targeted Urease Inhibition: An Updated Review from 2010 -2018
Current Protein & Peptide Science

A Review of Recent Advancements in Anti-tubercular Molecular Hybrids
Current Medicinal Chemistry

Anti-evolution Drugs: A New Paradigm to Combat Drug Resistance
Letters in Drug Design & Discovery

Pregnane X Receptor (PXR) at the Crossroads of Human Metabolism and Disease
Current Drug Metabolism

© 2024 Bentham Science Publishers | Privacy Policy